This is the first investigation of OXTR as a potential clinical epigenetic/genetic biomarker associated with PPD and further research in a population-based study is required before we can be certain that these results were not derived by chance. This evidence concerns the gene OXTR and progressive pseudorheumatoid arthropathy of childhood.